Pinnacle Associates LTD Astrazeneca PLC Transaction History

Pinnacle Associates LTD

  • $6.3 Billion
  • Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Pinnacle Associates LTD holds 26,246 shares of AZN stock, worth $1.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,246
Previous 31,057 15.49%
Holding current value
$1.72 Million
Previous $2.42 Million 15.57%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$76.67 - $87.62 $368,859 - $421,539
-4,811 Reduced 15.49%
26,246 $2.05 Million
Q2 2024

Jul 30, 2024
BUY
$66.81 - $80.83 $128,609 - $155,597
1,925 Added 6.61%
31,057 $2.42 Million
Q1 2024

Apr 26, 2024
BUY
$61.03 - $69.57 $176,132 - $200,779
2,886 Added 11.0%
29,132 $1.97 Million
Q4 2023

Jan 19, 2024
BUY
$61.89 - $69.28 $63,932 - $71,566
1,033 Added 4.1%
26,246 $1.77 Million
Q3 2023

Oct 23, 2023
SELL
$64.85 - $71.7 $12,386 - $13,694
-191 Reduced 0.75%
25,213 $1.71 Million
Q2 2023

Jul 26, 2023
BUY
$69.91 - $75.81 $169,811 - $184,142
2,429 Added 10.57%
25,404 $1.82 Million
Q1 2023

May 04, 2023
BUY
$63.15 - $71.6 $10,482 - $11,885
166 Added 0.73%
22,975 $1.59 Million
Q4 2022

Jan 31, 2023
BUY
$54.21 - $70.44 $29,815 - $38,742
550 Added 2.47%
22,809 $1.55 Million
Q4 2022

Jan 25, 2023
SELL
$54.21 - $70.44 $50,090 - $65,086
-924 Reduced 3.99%
22,259 $0
Q3 2022

Oct 31, 2022
SELL
$53.02 - $135.75 $49,626 - $127,062
-936 Reduced 3.88%
23,183 $1.27 Million
Q2 2022

Aug 02, 2022
SELL
$59.26 - $71.14 $149,868 - $179,913
-2,529 Reduced 9.49%
24,119 $1.59 Million
Q1 2022

May 05, 2022
BUY
$55.72 - $67.12 $79,846 - $96,182
1,433 Added 5.68%
26,648 $1.77 Million
Q4 2021

Feb 02, 2022
SELL
$54.02 - $63.83 $8,319 - $9,829
-154 Reduced 0.61%
25,215 $1.47 Million
Q3 2021

Oct 19, 2021
BUY
$55.56 - $60.79 $117,953 - $129,057
2,123 Added 9.13%
25,369 $1.52 Million
Q2 2021

Aug 02, 2021
BUY
$48.42 - $60.18 $29,681 - $36,890
613 Added 2.71%
23,246 $1.39 Million
Q1 2021

May 12, 2021
SELL
$47.16 - $54.44 $389,400 - $449,511
-8,257 Reduced 26.73%
22,633 $1.13 Million
Q4 2020

Jan 26, 2021
BUY
$48.52 - $58.02 $272,294 - $325,608
5,612 Added 22.2%
30,890 $1.54 Million
Q3 2020

Oct 23, 2020
SELL
$53.07 - $61.1 $30,462 - $35,071
-574 Reduced 2.22%
25,278 $1.39 Million
Q2 2020

Aug 14, 2020
SELL
$43.1 - $55.31 $544,137 - $698,288
-12,625 Reduced 32.81%
25,852 $1.37 Million
Q1 2020

May 13, 2020
BUY
$37.79 - $51.33 $2,531 - $3,439
67 Added 0.17%
38,477 $1.72 Million
Q4 2019

Feb 03, 2020
SELL
$42.46 - $50.46 $6,369 - $7,569
-150 Reduced 0.39%
38,410 $1.92 Million
Q3 2019

Nov 08, 2019
SELL
$40.12 - $45.47 $164,010 - $185,881
-4,088 Reduced 9.59%
38,560 $1.72 Million
Q2 2019

Aug 05, 2019
BUY
$37.28 - $41.68 $595,995 - $666,338
15,987 Added 59.96%
42,648 $1.76 Million
Q1 2019

May 10, 2019
BUY
$35.49 - $43.02 $536,076 - $649,817
15,105 Added 130.71%
26,661 $1.08 Million
Q4 2018

Feb 05, 2019
BUY
$36.86 - $41.49 $27,571 - $31,034
748 Added 6.92%
11,556 $439,000
Q3 2018

Nov 13, 2018
BUY
$34.76 - $39.72 $34,586 - $39,521
995 Added 10.14%
10,808 $428,000
Q2 2018

Aug 08, 2018
SELL
$34.55 - $37.05 $14,165 - $15,190
-410 Reduced 4.01%
9,813 $345,000
Q1 2018

May 11, 2018
SELL
$32.97 - $36.63 $66,038 - $73,369
-2,003 Reduced 16.38%
10,223 $357,000
Q4 2017

Feb 12, 2018
SELL
$32.09 - $34.78 $24,356 - $26,398
-759 Reduced 5.85%
12,226 $424,000
Q3 2017

Nov 13, 2017
BUY
$28.96 - $34.0 $3,909 - $4,590
135 Added 1.05%
12,985 $440,000
Q2 2017

Aug 09, 2017
BUY
N/A
12,850
12,850 $438,000

Others Institutions Holding AZN

# of Institutions
1,359
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email